EI
Exelixis Inc.
EXEL· Health Care· BiotechnologyS&P 400
Close · 10/09/2026
57.43
1D
-1.54%52-week range
33.76 – 59.72
Volume
17,89,500.00
Price history
EXEL
11/08/2026 to 10/09/2026
O 58.33 H 58.33 L 57.23
1W-1.88%
1M+11.88%
3M+9.22%
6M+37.56%
1Y+50.03%
3Y+157.88%
5Y+193.91%
MAX+222.10%
Fundamentals
as of 10/09/2026- Market cap
- $14.23B
- Shares out
- 247.78M
- P/E (trailing)
- 16.53
- P/E (forward)
- 13.85
- EPS (trailing)
- 3.47
- Beta
- 0.42
- Profit margin
- 35.33%
- P/B
- 7.72
- Return on equity
- 46.68%
SEC financial statements
67 quarterly and 19 annual periods through 03/07/2026.
Details
- Ticker
- EXEL
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.